WO2001023523A3 - Secreted proteins and uses thereof - Google Patents

Secreted proteins and uses thereof Download PDF

Info

Publication number
WO2001023523A3
WO2001023523A3 PCT/US2000/027202 US0027202W WO0123523A3 WO 2001023523 A3 WO2001023523 A3 WO 2001023523A3 US 0027202 W US0027202 W US 0027202W WO 0123523 A3 WO0123523 A3 WO 0123523A3
Authority
WO
WIPO (PCT)
Prior art keywords
tango
nucleic acid
family members
transmembrane
polypeptide
Prior art date
Application number
PCT/US2000/027202
Other languages
French (fr)
Other versions
WO2001023523A2 (en
Inventor
Susan Kirst
Nicholas Wrighton
Christopher C Fraser
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Priority to AU11908/01A priority Critical patent/AU1190801A/en
Publication of WO2001023523A2 publication Critical patent/WO2001023523A2/en
Publication of WO2001023523A3 publication Critical patent/WO2001023523A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

The invention provides isolated TANGO 315, TANGO 330, TANGO 437, and TANGO 480 nucleic acid molecules and polypeptide molecules. TANGO 315 family members encode transmembrane polypeptides related to CD33 and OB-BP-1. TANGO 330 family members encode transmembrane and secreted polypeptide related to roundabout. TANGO 437 family members encode a transmembrane polypeptide that contains an ion transport protein domain, a cell cycle protein domain and a putative permease domain. TANGO 480 family members encode a transmembrane polypeptide. The invention also provides antisense nucleic acid molecules, expression vectors containing the nucleic acid molecules of the invention, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a nucleic acid molecule of the invention has been introdued or disrupted. The invention still further provides isolated polypeptides, fusion polypeptides, antigenic peptides and antibodies. Diagnostic, screening and therapeutic methods utilizing compositions of the invention are also provided.
PCT/US2000/027202 1999-09-30 2000-10-02 Secreted proteins and uses thereof WO2001023523A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU11908/01A AU1190801A (en) 1999-09-30 2000-10-02 Secreted proteins and uses thereof

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40963499A 1999-09-30 1999-09-30
US09/409,634 1999-09-30

Publications (2)

Publication Number Publication Date
WO2001023523A2 WO2001023523A2 (en) 2001-04-05
WO2001023523A3 true WO2001023523A3 (en) 2001-10-04

Family

ID=23621344

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2000/027202 WO2001023523A2 (en) 1999-09-30 2000-10-02 Secreted proteins and uses thereof

Country Status (2)

Country Link
AU (1) AU1190801A (en)
WO (1) WO2001023523A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036771A2 (en) 2000-11-06 2002-05-10 Cancer Research Technology Limited Imaging, diagnosis and treatment of disease
EP1434866A2 (en) * 2001-10-01 2004-07-07 Ucb, S.A. Genes associated with mast cell activation
EP1565491B1 (en) 2002-11-20 2010-03-31 Cancer Research Technology Limited Antibodies binding to human magic roundabout (mr), polypeptides and uses thereof for inhibition of angiogenesis
MX2009008430A (en) 2007-02-09 2009-10-28 Genentech Inc Anti-robo4 antibodies and uses therefor.
KR20210060670A (en) 2008-12-09 2021-05-26 제넨테크, 인크. Anti-pd-l1 antibodies and their use to enhance t-cell function

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201105B1 (en) * 1989-09-05 2001-03-13 Craig A. Smith Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6201105B1 (en) * 1989-09-05 2001-03-13 Craig A. Smith Tumor necrosis factor receptor polypeptides recombinant P75 (Type II)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE EMBL [online] 1 January 1998 (1998-01-01), PATEL ET AL., XP002939131, Database accession no. AN015388 *
DATABASE GENBANK [online] 22 June 1999 (1999-06-22), YE ET AL.: "Human mRNA from cd34+ stem cells", XP002939130, Database accession no. AF150143 *

Also Published As

Publication number Publication date
AU1190801A (en) 2001-04-30
WO2001023523A2 (en) 2001-04-05

Similar Documents

Publication Publication Date Title
DE60033293D1 (en) NEW B7-4 MOLECULES AND THEIR USES
EP1190043A4 (en) Glycoprotein vi and uses thereof
WO1999066025A3 (en) Mtbx protein and nucleic acid molecules and uses therefor
EP1009752A4 (en) Novel molecules of the tango-77 related protein family and uses thereof
WO2000052047A3 (en) Human dickkopf-related protein and nucleic acid molecules and uses therefor
WO2002044354A3 (en) Molecules of the card-related protein family and uses thereof
WO2001000826A3 (en) Novel molecules of the card-related protein family and uses thereof
EP1710299A3 (en) Secreted proteins and nucleic acids encoding them
WO2000039149A3 (en) Secreted proteins and uses thereof
WO2001061005A3 (en) Molecules of the pyrin domain protein family and uses thereof
WO2001000673A8 (en) Membrane-associated and secreted proteins and uses thereof
WO2001023523A3 (en) Secreted proteins and uses thereof
WO2002061049A3 (en) Novel molecules of the pyrin/nbs/lrr protein family and uses thereof
WO2002068591A3 (en) G-protein coupled receptor nucleic acids, polypeptides, antibodies and uses thereof
WO2000008045A3 (en) Novel molecules of the tango-93-related protein family and uses thereof
WO1999054437A3 (en) Novel molecules of the t125-related protein family and uses thereof
WO2001030971A3 (en) Novel molecules and the card-related protein family and uses thereof
WO2000050443A3 (en) Secreted proteins and uses thereof
WO2002085939A8 (en) Novel molecules of the card-related protein family and uses thereof
WO2001083753A3 (en) Molecules of the nbs/lrr protein family and uses thereof
WO2000018923A3 (en) Slgp protein and nucleic acid molecule and uses therefor
WO1999062943A3 (en) Novel molecules of the aip-related protein family and uses thereof
WO2000050442A3 (en) Secreted proteins and uses thereof
WO2001096400A3 (en) 52871, a novel human g protein coupled receptor and uses thereof
WO2001014414A3 (en) Human abc2 transporter and uses thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP